Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Mueller

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Burn Care & Research : Official Publication of the American Burn Association|February 29, 2024
Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosaScott W Mueller, Kyle C Molina, Brittany Blass, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|September 29, 2022
Burn Injury and Augmented Renal Clearance: A Case for Optimized Piperacillin-Tazobactam DosingSterling C Torian, Arek J Wiktor, Sara E Roper, et al.
Annals of Clinical Microbiology and Antimicrobials|March 22, 2019
Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical centerEdward T Van Matre, Shelby L Evans, Scott W Mueller, et al.
Annals of Clinical Microbiology and Antimicrobials|September 13, 2017
Voriconazole and posaconazole therapeutic drug monitoring: a retrospective studyWhitley M Yi, Kelly E Schoeppler, Jaclyn Jaeger, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 8, 2018
A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infectionsMatthew A Miller, Douglas N Fish, Gerard R Barber, et al.
Critical Care Medicine|December 20, 2013
A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawalScott W Mueller, Candice R Preslaski, Tyree H Kiser, et al.
Open Forum Infectious Diseases|February 3, 2022
Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill PatientsAlison R Novak, Martin Krsak, Tyree H Kiser, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|December 13, 2024
Vasoactive Agents in Burn Patients - Perspectives on Angiotensin-IIScott W Mueller, Nicolas M Tran, Kevin D Betthauser, et al.
Journal of Intensive Care Medicine|November 15, 2013
A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomesRobert MacLaren, Candice R Preslaski, Scott W Mueller, et al.
Journal of Intensive Care Medicine|July 21, 2016
Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside InfusionsAmanda A Morris, Robert L Page, Laura J Baumgartner, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Burn Care & Research : Official Publication of the American Burn Association|February 29, 2024
Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosaScott W Mueller, Kyle C Molina, Brittany Blass, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|September 29, 2022
Burn Injury and Augmented Renal Clearance: A Case for Optimized Piperacillin-Tazobactam DosingSterling C Torian, Arek J Wiktor, Sara E Roper, et al.
Annals of Clinical Microbiology and Antimicrobials|March 22, 2019
Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical centerEdward T Van Matre, Shelby L Evans, Scott W Mueller, et al.
Annals of Clinical Microbiology and Antimicrobials|September 13, 2017
Voriconazole and posaconazole therapeutic drug monitoring: a retrospective studyWhitley M Yi, Kelly E Schoeppler, Jaclyn Jaeger, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 8, 2018
A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infectionsMatthew A Miller, Douglas N Fish, Gerard R Barber, et al.
Critical Care Medicine|December 20, 2013
A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawalScott W Mueller, Candice R Preslaski, Tyree H Kiser, et al.
Open Forum Infectious Diseases|February 3, 2022
Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill PatientsAlison R Novak, Martin Krsak, Tyree H Kiser, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|December 13, 2024
Vasoactive Agents in Burn Patients - Perspectives on Angiotensin-IIScott W Mueller, Nicolas M Tran, Kevin D Betthauser, et al.
Journal of Intensive Care Medicine|November 15, 2013
A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomesRobert MacLaren, Candice R Preslaski, Scott W Mueller, et al.
Journal of Intensive Care Medicine|July 21, 2016
Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside InfusionsAmanda A Morris, Robert L Page, Laura J Baumgartner, et al.
Pageof 7